| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |